Primary Recipient

ZACHARON PHARMACEUTICALS, INC.

Amount

$175,000.00

Award Date

9/09/2010

Administering Agency

Health and Human Services, Department of / National Institutes of Health

CDFA Number

93.701

CDFA Program Title

Trans-NIH Recovery Act Research Support

Description

The purpose of the supplement is to accelarate our anticancer compounds toward clinical testing. These novel compounds are the first pharmacologically relevant inhibtiors of gangliosides; a class of lipid-linked glycans known to be key melanoma and neur